Výsledky vyhledávání - "Paul M, Yonover"

Akademický článek

CASE DISCUSSION WITH PAUL M. YONOVER, MD, FACS: A 66-year-old man with prostate cancer.

Publikováno v: Urology Times. Dec2023, Vol. 51 Issue 12, p18-19. 2p.

Akademický článek

Clinical utility of urinary comprehensive genomic profiling in diagnosing metachronous upper tract urothelial carcinoma: a case report

Autor: Paul M. Yonover, Ceressa T. Ward, Brian C. Mazzarella, Kevin G. Phillips, Brad W. Jensen, Vincent T. Bicocca, Kathleen Duffy, Jaden Yonover, Ava Cherry, Trevor G. Levin

Publikováno v: Frontiers in Urology, Vol 3 (2023)

Introduction and aim of studyMetachronous upper tract urothelial carcinoma (UTUC) is a rare yet aggressive malignancy that is often multifocal and invasive at the time of diagnosis. Unfortunately, the rarity of metachronous UTUC results in a paucity

Externí odkaz: https://doaj.org/article/0f8c398d201c4d34b8cd901db2a21527

Zobrazit plný text záznamu

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Fluorine-18-Labeled Fluciclovine PET/CT in Clinical Practice: Factors Affecting the Rate of Detection of Recurrent Prostate Cancer

Autor: David M. Schuster, Gopal N. Gupta, Bital Savir-Baruch, Abhishek A. Solanki, Petra Lovrec, William Adams, Paul M. Yonover

Publikováno v: AJR. American journal of roentgenology. 213(4)

OBJECTIVE. The purpose of this study is to show the performance and evaluate the factors influencing the positivity rate (PR) of commercially produced 18F-fluciclovine PET/CT in the detection of recurrent prostate cancer in clinical practice. MATERIA

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::198e6e29105cbdc1f7e27331a795f2ab
https://pubmed.ncbi.nlm.nih.gov/31216198

Zobrazit plný text záznamu

Metastatic Male Breast Cancer With Increased Uptake on 18F-Fluciclovine PET/CT Scan

Autor: Bital Savir-Baruch, David T. Greenwald, Funmilayo Tade, Harkanwar S. Gill, Paul M. Yonover

Publikováno v: Clinical Nuclear Medicine. 43:23-24

Prostate imaging with F-labeled 1-amino-3-fluorocyclobutane-1-carboxylic acid (FACBC, F-fluciclovine) PET/CT scan (Axumin) was recently approved by the US Food and Drug Administration for men with suspected prostate cancer recurrence based on elevate

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3a2ea638e13ff8ebb1f47fa98b372895
https://doi.org/10.1097/rlu.0000000000001893

Zobrazit plný text záznamu

Case Report of a Ureterocutenous Fistula Post Aortobifemoral Bypass Graft Removal in a Patient With Obstructive UPJ Calculus

Autor: Harpreet Wadhwa, Matthew J. Blecha, Paul M. Yonover, Jason Huang

Publikováno v: Urology Case Reports, Vol 13, Iss C, Pp 53-54 (2017)
Urology Case Reports

Ureterocutaneous fistulas are rare, often iatrogenic complications. We present a case of a 60 year old woman suffering a ureterocutaneous fistula in association with an infected vascular graft. Percutaneous diversion of urinary fluid with a nephrosto

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::39672def596d47f011f6c55dbb40bc57
http://www.sciencedirect.com/science/article/pii/S2214442016301425

Zobrazit plný text záznamu

Small Cell Carcinoma of the Prostate: A Case Report and Brief Review of the Literature

Autor: Paul M. Yonover, Samuel Weprin

Publikováno v: Urology Case Reports
Urology Case Reports, Vol 13, Iss C, Pp 61-62 (2017)

Small cell carcinoma of the prostate (SCCP) is a rare disorder. We present here a case of SCCP exhibiting multiple unique clinical findings, demonstrating the variability of SCCP at presentation.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::78a1ccfc73b07790fb8897902799d8e1
http://europepmc.org/articles/PMC5408139

Zobrazit plný text záznamu

Occurrence of pathologic stage T3 disease at radical prostatectomy with isup grade group 1 (Gleason 3+3=6) prostate cancer

Autor: Paul M. Yonover, Jason Huang, Harpreet Wadhwa, David T. Greenwald, Alice Y. Wang, Tony Nimeh, Justin J. Cohen

Publikováno v: Journal of Clinical Oncology. 36:21-21

21 Background: Treatment of ISUP Grade Group 1 (Gleason 3+3 = 6) disease continues to evolve in the modern era. We examined our surgical database to investigate patterns of behavior in this pathologic subset. Methods: We reviewed the results of 1127

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::55eadc8ee1f91d3f143bae06342222a5
https://doi.org/10.1200/jco.2018.36.6_suppl.21

Zobrazit plný text záznamu